Bonlon Industries Ltd: Intrinsic Value & Share Price Analysis

Last Updated: January 2, 2026, 5:10 pm

All Competitor Stocks of Bonlon Industries Ltd

Last Updated: December 27, 2025, 5:36 pm

Below is a detailed analysis of the quarterly data for Bonlon Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Sales, as of Sep 2025, the value is 242.00 Cr.. The value appears strong and on an upward trend. It has increased from 180.30 Cr. (Jun 2025) to 242.00 Cr., marking an increase of 61.70 Cr..
• For Expenses, as of Sep 2025, the value is 244.16 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 175.01 Cr. (Jun 2025) to 244.16 Cr., marking an increase of 69.15 Cr..
• For Operating Profit, as of Sep 2025, the value is -2.16 Cr.. The value appears to be declining and may need further review. It has decreased from 5.29 Cr. (Jun 2025) to -2.16 Cr., marking a decrease of 7.45 Cr..
• For OPM %, as of Sep 2025, the value is -0.89%. The value appears to be declining and may need further review. It has decreased from 2.93% (Jun 2025) to -0.89%, marking a decrease of 3.82%.
• For Other Income, as of Sep 2025, the value is 0.34 Cr.. The value appears to be declining and may need further review. It has decreased from 0.42 Cr. (Jun 2025) to 0.34 Cr., marking a decrease of 0.08 Cr..
• For Interest, as of Sep 2025, the value is 0.67 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.66 Cr. (Jun 2025) to 0.67 Cr., marking an increase of 0.01 Cr..
• For Depreciation, as of Sep 2025, the value is 0.34 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.32 Cr. (Jun 2025) to 0.34 Cr., marking an increase of 0.02 Cr..
• For Profit before tax, as of Sep 2025, the value is -2.83 Cr.. The value appears to be declining and may need further review. It has decreased from 4.73 Cr. (Jun 2025) to -2.83 Cr., marking a decrease of 7.56 Cr..
• For Tax %, as of Sep 2025, the value is -25.09%. The value appears to be improving (decreasing) as expected. It has decreased from 24.52% (Jun 2025) to -25.09%, marking a decrease of 49.61%.
• For Net Profit, as of Sep 2025, the value is -2.12 Cr.. The value appears to be declining and may need further review. It has decreased from 3.57 Cr. (Jun 2025) to -2.12 Cr., marking a decrease of 5.69 Cr..
• For EPS in Rs, as of Sep 2025, the value is -1.49. The value appears to be declining and may need further review. It has decreased from 2.52 (Jun 2025) to -1.49, marking a decrease of 4.01.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Last Updated: December 15, 2025, 4:02 am

Last Updated: September 5, 2025, 2:46 pm

Last Updated: December 10, 2025, 3:59 am

Below is a detailed analysis of the balance sheet data for Bonlon Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 14.00 Cr..
• For Reserves, as of Sep 2025, the value is 69.00 Cr.. The value appears strong and on an upward trend. It has increased from 67.00 Cr. (Mar 2025) to 69.00 Cr., marking an increase of 2.00 Cr..
• For Borrowings, as of Sep 2025, the value is 41.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 31.00 Cr. (Mar 2025) to 41.00 Cr., marking an increase of 10.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 36.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 16.00 Cr. (Mar 2025) to 36.00 Cr., marking an increase of 20.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 161.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 128.00 Cr. (Mar 2025) to 161.00 Cr., marking an increase of 33.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 22.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Mar 2025) to 22.00 Cr., marking an increase of 7.00 Cr..
• For CWIP, as of Sep 2025, the value is 5.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 5.00 Cr., marking an increase of 5.00 Cr..
• For Investments, as of Sep 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Mar 2025) to 6.00 Cr., marking a decrease of 3.00 Cr..
• For Other Assets, as of Sep 2025, the value is 128.00 Cr.. The value appears strong and on an upward trend. It has increased from 104.00 Cr. (Mar 2025) to 128.00 Cr., marking an increase of 24.00 Cr..
• For Total Assets, as of Sep 2025, the value is 161.00 Cr.. The value appears strong and on an upward trend. It has increased from 128.00 Cr. (Mar 2025) to 161.00 Cr., marking an increase of 33.00 Cr..

Notably, the Reserves (69.00 Cr.) exceed the Borrowings (41.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

After reviewing the key financial ratios for Bonlon Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 21) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 1.89. This value is below the healthy minimum of 5. It has increased from 1.39 (Mar 21) to 1.89, marking an increase of 0.50.
• For Diluted EPS (Rs.), as of Mar 25, the value is 1.89. This value is below the healthy minimum of 5. It has increased from 1.39 (Mar 21) to 1.89, marking an increase of 0.50.
• For Cash EPS (Rs.), as of Mar 25, the value is 3.03. This value is within the healthy range. It has increased from 1.60 (Mar 21) to 3.03, marking an increase of 1.43.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 57.57. It has increased from 51.37 (Mar 21) to 57.57, marking an increase of 6.20.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 57.57. It has increased from 51.37 (Mar 21) to 57.57, marking an increase of 6.20.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 439.32. It has increased from 111.52 (Mar 21) to 439.32, marking an increase of 327.80.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 5.03. This value is within the healthy range. It has increased from 2.22 (Mar 21) to 5.03, marking an increase of 2.81.
• For PBIT / Share (Rs.), as of Mar 25, the value is 3.89. This value is within the healthy range. It has increased from 2.01 (Mar 21) to 3.89, marking an increase of 1.88.
• For PBT / Share (Rs.), as of Mar 25, the value is 2.52. This value is within the healthy range. It has increased from 1.87 (Mar 21) to 2.52, marking an increase of 0.65.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 1.89. This value is below the healthy minimum of 2. It has increased from 1.39 (Mar 21) to 1.89, marking an increase of 0.50.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 1.89. This value is below the healthy minimum of 2. It has increased from 1.39 (Mar 21) to 1.89, marking an increase of 0.50.
• For PBDIT Margin (%), as of Mar 25, the value is 1.14. This value is below the healthy minimum of 10. It has decreased from 1.99 (Mar 21) to 1.14, marking a decrease of 0.85.
• For PBIT Margin (%), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 10. It has decreased from 1.80 (Mar 21) to 0.88, marking a decrease of 0.92.
• For PBT Margin (%), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 10. It has decreased from 1.68 (Mar 21) to 0.57, marking a decrease of 1.11.
• For Net Profit Margin (%), as of Mar 25, the value is 0.43. This value is below the healthy minimum of 5. It has decreased from 1.24 (Mar 21) to 0.43, marking a decrease of 0.81.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.43. This value is below the healthy minimum of 8. It has decreased from 1.24 (Mar 21) to 0.43, marking a decrease of 0.81.
• For Return on Networth / Equity (%), as of Mar 25, the value is 3.28. This value is below the healthy minimum of 15. It has increased from 2.69 (Mar 21) to 3.28, marking an increase of 0.59.
• For Return on Capital Employeed (%), as of Mar 25, the value is 6.47. This value is below the healthy minimum of 10. It has increased from 3.90 (Mar 21) to 6.47, marking an increase of 2.57.
• For Return On Assets (%), as of Mar 25, the value is 2.09. This value is below the healthy minimum of 5. It has increased from 1.72 (Mar 21) to 2.09, marking an increase of 0.37.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 21) to 0.04, marking an increase of 0.04.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.37. This value is within the healthy range. It has increased from 0.04 (Mar 21) to 0.37, marking an increase of 0.33.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. It has decreased from 1.07 (Mar 21) to 0.00, marking a decrease of 1.07.
• For Current Ratio (X), as of Mar 25, the value is 2.39. This value is within the healthy range. It has increased from 2.15 (Mar 21) to 2.39, marking an increase of 0.24.
• For Quick Ratio (X), as of Mar 25, the value is 2.08. This value exceeds the healthy maximum of 2. It has increased from 1.90 (Mar 21) to 2.08, marking an increase of 0.18.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. There is no change compared to the previous period (Mar 21) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.68. This value is within the healthy range. It has decreased from 16.35 (Mar 21) to 3.68, marking a decrease of 12.67.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.39. This value is below the healthy minimum of 3. It has decreased from 11.19 (Mar 21) to 2.39, marking a decrease of 8.80.
• For Enterprise Value (Cr.), as of Mar 25, the value is 41.56. It has increased from 23.56 (Mar 21) to 41.56, marking an increase of 18.00.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 1. It has decreased from 0.14 (Mar 21) to 0.06, marking a decrease of 0.08.
• For EV / EBITDA (X), as of Mar 25, the value is 5.83. This value is within the healthy range. It has decreased from 7.47 (Mar 21) to 5.83, marking a decrease of 1.64.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 1. It has decreased from 0.16 (Mar 21) to 0.06, marking a decrease of 0.10.
• For Price / BV (X), as of Mar 25, the value is 0.49. This value is below the healthy minimum of 1. It has increased from 0.35 (Mar 21) to 0.49, marking an increase of 0.14.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 1. It has decreased from 0.16 (Mar 21) to 0.06, marking a decrease of 0.10.
• For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 21) to 0.06, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

About the Company - Qualitative Analysis